Sirtris Pharmaceuticals, Inc.

Contact

Site Map

Sirtris is focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, such as Type 2 Diabetes. Our research focus is on modulating the sirtuins, a recently discovered class of enzymes involved in the aging process.

Sirtris, a GSK company www.gsk.com

+ 06.03.09	Sirtris CEO presented at Boston Biotech CEO Conference
+ 05.08.09	Sirtris CEO presented Harvard Business School case entitled "GSK's Acquisition of Sirtris: Independence or Integration?"
+ 04.02.09	Sirtris CEO presented Harvard Business School case entitled "Living Healthier, Longer"
+ 03.20.09	George Vlasuk, Ph.D., has been appointed to the position of President and Head of Sirtris
+ 03.04.09	Sirtris links SIRT1 and AMPK as key metabolic regulators; study published in Nature

Find information regarding our clinical trials and areas of research. Learn more

+ 09.23.09

Sirtris Presents at the Aging & Healthy Lifespan Conference

Sirtris is looking for an exceptional Head of Clinical Development/CMO to join our dynamic team. If you’re interested in this position or other exciting career opportunities at Sirtris, click here.